Concepedia

Author

Alan Kivitz

Altoona Center for Clinical ResearchORCID

Also Known As

A J Kivitz, A Kivitz, A. J. Kivitz, A. Kivitz, A.J. Kivitz, ALAN J. KIVITZ, Alan J Kivitz, Alan J. Kivitz, Alan Kivitz, Kivits, Joëlle

350

Publications

19.5K

Citations

74

H-Index

64

Concepts

All Affiliations

Altoona Center for Clinical ResearchCharité - Universitätsmedizin BerlinStanford UniversityMetroplex Clinical Research CenterOregon Health & Science University
AK

About

Alan Kivitz is an author at Altoona Center for Clinical Research specializing in medicine, rheumatology, and rheumatoid arthritis.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

28

37

3.8K

2

Health Sciences

6

6

367

3

Allergy

3

3

103

4

Clinical Immunology

1

1

14

5

Endocrinology

1

1

113

Alan Kivitz

×

177

Publications

18.6K

Citations

72

H-Index

YearCitations

Denosumab in Postmenopausal Women with Low Bone Mineral Density

Michael R. McClung, E. Michael Lewiecki, Stanley Cohen,

New England Journal of Medicine

2006

1.2K

Etanercept treatment of psoriatic arthritis: Safety, efficacy, and effect on disease progression

Philip J. Mease, Alan Kivitz, Francis X. Burch,

Arthritis & Rheumatism

2004

882

Efficacy and safety of adalimumab in patients with ankylosing spondylitis: Results of a multicenter, randomized, double‐blind, placebo‐controlled trial

Désirée van der Heijde, Alan Kivitz, Michael Schiff,

Arthritis & Rheumatism

2006

874

Anti-inflammatory and Upper Gastrointestinal Effects of Celecoxib in Rheumatoid Arthritis

Lee S. Simon, Arthur L. Weaver, David Y. Graham,

JAMA

1999

803

Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: A randomized, controlled trial

John C. Davis, Désirée van der Heijde, Jürgen Braun,

Arthritis & Rheumatism

2003

762

Efficacy and safety of rilonacept (interleukin‐1 trap) in patients with cryopyrin‐associated periodic syndromes: Results from two sequential placebo‐controlled studies

Hal M. Hoffman, M. Throne, N. Amar,

Arthritis & Rheumatism

2008

572

Intraarticular injection of anakinra in osteoarthritis of the knee: A multicenter, randomized, double‐blind, placebo‐controlled study

Xavier Chevalier, Philippe Goupille, A. D. Beaulieu,

Arthritis Care & Research

2009

512

Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial

Roy Fleischmann, Eduardo Mysler, Stephen Hall,

The Lancet

2017

479

Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial

Peter Nash, Bruce Kirkham, Masato Okada,

The Lancet

2017

390

Safety and efficacy of upadacitinib in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying anti-rheumatic drugs (SELECT-NEXT): a randomised, double-blind, placebo-controlled phase 3 trial

Gerd R Burmester, Joel M. Kremer, Filip Van den Bosch,

The Lancet

2018

373

Page 1